BioNTech SE (BNTX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | ||||
Total Assets | 23.28B | 22.08B | 22.23B | 22.21B | 23.01B | 22.26B | 22.24B | 22.4B |
Total Current Assets | 21.92B | 20.09B | 19.21B | 18.75B | 19.53B | 18.27B | 18.28B | 18.49B |
Cash and Equivalents | 13.88B | 12.14B | 14.17B | 13.5B | 11.66B | 8.98B | 10.38B | 9.62B |
Total Non-Current Assets | 1.75B | 1.78B | 2.81B | 3.26B | 4.02B | 3.75B | 3.7B | 3.67B |
Total Liabilities | 3.22B | 1.81B | 2.32B | 2.34B | 2.76B | 2.29B | 3.17B | 3.29B |
Total Current Liabilities | 2.95B | 1.55B | 1.82B | 1.81B | 2.07B | 1.61B | 2.43B | 2.52B |
Total Non-Current Liabilities | 449.1M | 435.2M | 667.2M | 695.1M | 880.9M | 887.6M | 959M | 970.5M |
Common Equity | 248.6M | 248.6M | 248.6M | 248.6M | 248.6M | 248.6M | 248.6M | 248.6M |
Retained Earnings | 18.83B | 19.34B | 19.14B | 19.31B | 19.76B | 19.45B | 18.64B | 18.84B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 797.65M | 2.32B | 15.83B | 23.28B | 23.01B |
Total Current Assets | 560.15M | 1.67B | 15.07B | 21.92B | 19.53B |
Cash and Equivalents | 519.15M | 1.21B | 1.69B | 13.88B | 11.66B |
Total Non-Current Assets | 493.49M | 1.37B | 11.89B | 20.06B | 20.25B |
Total Liabilities | 304.16M | 946.77M | 3.94B | 3.22B | 2.76B |
Total Current Liabilities | 138.14M | 606.01M | 3.48B | 2.95B | 2.07B |
Total Non-Current Liabilities | 234.92M | 571.81M | 627.1M | 449.1M | 880.9M |
Total Equity | 493.49M | 1.37B | 11.89B | 20.06B | 20.25B |
Common Equity | 232.3M | 246.31M | 246.3M | 248.6M | 248.6M |
Retained Earnings | -424.83M | -409.63M | 9.88B | 18.83B | 19.76B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.